- Even sporadic transmission from persistently infected carrier hosts can allow contagious pathogens to persist in host populations
- Foot-and-mouth disease virus (FMDV) persistence in African buffalo, the wildlife host, enabled by low level transmission by carrier animals
- Different serotypes of FMDV transmit with varying effectiveness from carrier animals to naive populations
A major new study, featured on the cover of Science Magazine on1 October 2021, undertaken by scientists at The Pirbright Institute, Oregon State University, Onderstepoort Veterinary Institute and SANParks, Veterinary Wildlife Services, Kruger National Park explores the mechanisms at play that enable the persistence of highly infectious pathogens in their host populations, a major problem in endemic disease ecology. The research, which combined experimental and theoretical approaches, focused on highly contagious foot-and-mouth disease viruses (FMDV) persistence in their wildlife reservoir, African buffalo. Foot-and-mouth disease (FMD) is endemic in many low-middle income countries creating an economic burden and threatening food security. FMD does not cause disease in buffalo, but in cloven-footed animals like cattle it causes painful blisters on the mouth and feet resulting in weight loss and reduction in milk yield.
To solve the puzzle of how some contagious diseases are able to persist and continue circulating in a population long after an initial outbreak when the disease first burns through a pool of susceptible hosts, scientists set up experiments in the field to investigate the transmission of three main strains of FMDV (SAT1, SAT2 and SAT3) in buffalo herds in South Africa’s Kruger National Park. Researchers sampled blood and tissue from a wild herd at two monthly intervals over a period of three years to test for FMDV while simultaneously recording infection dynamics in a captive group of experimentally infected buffalo over a six month period.
The aim was to work out what the virus was doing in between outbreaks and how it was able to maintain itself in a population once the initial ‘wildfire’ infection was over. FMDV is extremely contagious and able to infect entire buffalo populations in areas where it is circulating, providing some level of immunity in young animals. This immunity wanes considerably at around 4-6 months of age when young calves lose their maternally-derived antibodies making them susceptible to infection. The researchers therefore focused on this primary path of transmission in the study as well as investigating a second transmission route via carrier animals, which was thought to be a less effective transmission route but a potential factor in preventing FMDV fade out between successive calving seasons.
The experimental challenge study was designed to measure the epidemiological parameters for FMDV transmission in buffalo during primary (acute) infection and from carrier hosts for each of the three strains. To assess primary transmission four naïve buffalo were allowed contact with four animals experimentally infected with one of the three FMDV strains being tested, a total of 12 naïve and 12 infected animals which were observed over 30 days. In the carrier buffalo study, transmission was assessed by monitoring two groups of buffalo, each group containing two carriers for each strain (6 buffalo) along with 6 naïve buffalo.
In the primary transmission group all naïve animals became infected and became carriers. Unlike previous studies the researchers were able to show that carrier transmission does occur, but at a rate that was considerably lower than in primary infection. Importantly, both the direct and carrier transmission rates differed amongst the three strains.
Based on the results of the experiments, scientists used mathematical models to establish that none of the strains would be able to persist in populations from one birthing season to another if the buffalo didn’t become carriers and therefore ‘childhood infection’ alone is not sufficient to explain how the virus becomes endemic. However, when carrier transmission was included in the models, SAT 1 and SAT 3 were able to persist in buffalo, even in small populations of around 2000 animals. Conversely, although SAT 2 spreads efficiently in acute infections, it performs less well in carrier transmission and was not able to persist in small populations.
“Understanding the significance of FMD persistently infected animals that carry the virus for many months or years has been a major goal of this research,” said Dr Simon Gubbins, Head of Transmission Biology at The Pirbright Institute. “Why does a virus that spreads so rapidly, R numbers greater than 20 or more have been reported, need to persist at low levels? Our work shows this long-term carriage in the reservoir host allows the virus to persist in an immune population until new susceptible animals become available.” Professor Bryan Charleston, Director of The Pirbright Institute added: “It is also clear from our previous research that new virus variants are produced during this long-term carriage. Another important finding from this study is that some viruses transmit efficiently from carriers, but other strains of the virus do not. Buffalo sometimes mix with farmed cattle causing outbreaks of disease, in other cases there is no transmission. Our work suggests one of the reasons for this difference depends on the virus variant the buffalo are carrying.”
ENDS
For more information please contact communications@pirbright.ac.uk
Tel: +44 (0) 1483 231120.
Notes to Editors
The paper ‘Endemic persistence of a highly contagious pathogen: Foot-and-mouth disease in its wildlife host’ will be available in Science on the link https://doi.org/10.1126/science.abd2475.
This research was supported by USDA-NIFA AFRI grant 2013-67015-21291 and by the UK Biotechnology and Biological Sciences Research Council grant BB/L011085/1 as part of the joint USDA-NSF-NIHBBSRC Ecology and Evolution of Infectious Diseases program, UK Biotechnology and Biological Sciences Research Council grants BBS/E/I/00007032, BBS/E/I/00007036, and BBS/E/I/00007037.
About The Pirbright Institute
The Pirbright Institute is a world leading centre of excellence in research and surveillance of virus diseases of farm animals and viruses that spread from animals to humans. Based in the UK and receiving strategic funding from the Biotechnology and Biological Sciences Research Council (BBSRC) part of UK Research and Innovation (UKRI), the Institute works to enhance capability to contain, control and eliminate these economically and medically important diseases through highly innovative fundamental and applied bioscience.
The Institute is an independent company, limited by guarantee and a registered charity, governed by a Board of non-executive Trustee Directors.
With an annual income of £37 million from grants and commercial activity, and a total of £43.7 million strategic investment from BBSRC UKRI during 2021-2022, the Institute contributes to global food security and health, improving quality of life for animals and people.
For more information about The Pirbright Institute see: www.pirbright.ac.uk
Follow The Pirbright Institute on social media: Facebook Twitter Linkedin
About BBSRC
The Biotechnology and Biological Sciences Research Council (BBSRC) is part of UK Research and Innovation, a non-departmental public body funded by a grant-in-aid from the UK government.
BBSRC invests in world-class bioscience research and training on behalf of the UK public. Our aim is to further scientific knowledge, to promote economic growth, wealth and job creation and to improve quality of life in the UK and beyond.
Funded by government, BBSRC invested £451 million in world-class bioscience in 2019-20. We support research and training in universities and strategically funded institutes. BBSRC research and the people we fund are helping society to meet major challenges, including food security, green energy and healthier, longer lives. Our investments underpin important UK economic sectors, such as farming, food, industrial biotechnology and pharmaceuticals.
More information about BBSRC UKRI, its science and its impact: www.bbsrc.ukri.org
More information about BBSRC UKRI strategically funded institutes